LNCaP-ENZR-1
Homo sapiens
source_name
prostate
tissue
prostate
cell line
LNCaP
cell type
Human prostate cancer cells
genotype
resistant to enzalutamide
treatment
LNCaP cells were gradually exposed to increased concentration of enzalutamide (ranging from 5 μM to 50 μM) in media supplemented with 10% charcoal-stripped FBS (CSS) (HyClone; SH30068) for over 12 months
geo_loc_name
missing
collection_date
missing